Honasa Consumer Limited
NSE: HONASAPersonal Care
Share price
₹467.50
-2.00% close of 8 Oct 2026
Business score
How strong the business is, in one number. The parts behind it are in Pro.
66
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹15,194 Cr
P/E ratio
60.3
P/B ratio
10.8
ROCE
19.2%
ROE
15.7%
Dividend yield
0.6%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 21.1% over the past year, and 14.4% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 3.8% to 11.5% over the last three years.
Whether it grew faster than its sector
It grew 14.4% a year against a sector median of 9.9% — 4.5 percentage points faster.
Room to re-rate, or risk of de-rating
Too little price history yet to compare it with its own past.
Whether growth justifies the valuation
Priced at 0.5 times its growth rate, on earnings growth of 118%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Honasa Consumer Limited — this one | 118%/yr | 60.3× | — |
| Godrej Consumer Products | 5%/yr | 42.5× | ₹8.5 |
| Dabur India | 4%/yr | 33.6× | ₹8.4 |
| Cupid Limited | — | 348.8× | — |
| Colgate-Palmolive India | 8%/yr | 34.8× | ₹4.3 |
| Gillette India Limited | 31%/yr | 35.9× | ₹1.2 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Personal Care), it ranks 8 of 10 on returns, 3 of 10 on growth, 9 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 19.2% on capital, ahead of 20% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹471 crore of cash from the business and spent ₹52 crore on plant and equipment, with ₹419 crore to spare; it still raised ₹735 crore from shareholders — borrowings did not rise. It has not made a profit over 6 years.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
8 of 9 checks clear · 89%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Sales up 32% and the three-year sales-mix goal already reached in the first quarter
Announced 13 Aug 2026 · Consolidated · Unaudited
Revenue
₹756 Cr
Revenue vs last year
+27.0%
Revenue vs last quarter
+15.1%
Net profit
₹90 Cr
Profit vs last year
+120.6%
Profit vs last quarter
+31.1%
Net margin
12.0%
EPS
₹2.77
Earnings call transcript · 13 Aug 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹15,194 Cr
- Prev close
- ₹467.50
- 52w High
- ₹510
- 52w Low
- ₹248
- Enterprise value
- ₹14,863 Cr
- Beta
- 0.8
- Price CAGR 1y
- 68.0%
- Price CAGR 3y
- —
- Price CAGR 5y
- —
- Price CAGR 10y
- —
Ratios
- Return on assets
- 9.5%
- PEG ratio
- 0.5
- P/E ratio
- 60.3
- P/B ratio
- 10.8
- EV / EBITDA
- 49.5
- Industry P/E
- 34.7
- ROCE
- 19.2%
- ROCE 5y average
- 10.2%
- ROE
- 15.7%
- Debt / Equity
- 0.1
- Interest coverage
- 20.8
- Dividend yield
- 0.6%
- ROE 3y average
- —
- ROE last year
- 16.0%
Annual P&L
- Annual revenue
- ₹2,392 Cr
- Annual profit
- ₹200 Cr
- Operating margin
- 10.0%
- Net profit margin
- 8.4%
- EBITDA margin
- 9.9%
- Sales growth 3y
- 17.0%
- Sales growth 5y
- 39.1%
- Profit growth 3y
- 118.0%
- Profit growth 5y
- 17.0%
- EPS
- ₹6.2
- Sales growth TTM
- 21.0%
- Profit growth TTM
- 242.0%
- Dividend payout
- 49.0%
Quarter P&L
- Sales latest quarter
- ₹756 Cr
- Profit latest quarter
- ₹90 Cr
- YoY quarterly sales growth
- 27.0%
- YoY quarterly profit growth
- 119.5%
- OPM latest quarter
- 14.6%
Balance Sheet
- Book Value
- ₹43.4
- Face Value
- ₹10.0
- Total debt
- ₹135 Cr
- Total cash
- ₹214 Cr
- Borrowings
- ₹135 Cr
- Reserves / Equity
- 3.3
Cash Flow
- Operating cash flow
- ₹141 Cr
- Free cash flow
- ₹134 Cr
- FCF yield
- 0.8%
- Net cash flow
- ₹86 Cr
Shareholding
- Promoter holding
- 35.5%
- FII holding
- 13.6%
- DII holding
- 21.6%
- Public holding
- 29.3%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Consumer | 865.55 | 42.7 | 88,572 | 2.31 | 504.5 | 10.6 | 4,225.5 | 15.4 | 18.8 |
| Dabur India | 383.55 | 34.3 | 68,040 | 2.15 | 586.2 | 15.0 | 3,764.4 | 10.6 | 20.3 |
| Colgate-Palmoliv | 1,757.40 | 34.9 | 47,799 | 2.73 | 343.1 | 7.8 | 1,603.3 | 11.8 | 108.0 |
| Cupid | 343.95 | 336.6 | 46,250 | 0.00 | 44.2 | 194.0 | 157.0 | 142.5 | 33.9 |
| Gillette India | 7,223.50 | 35.2 | 23,541 | 2.49 | 159.5 | 9.4 | 783.0 | 10.8 | 90.7 |
| P & G Hygiene | 6,921.00 | 28.4 | 22,466 | 3.32 | 126.3 | -34.3 | 891.5 | -4.9 | 157.2 |
| Emami | 375.45 | 21.6 | 16,388 | 2.66 | 138.9 | -16.4 | 1,039.2 | 14.9 | 28.1 |
| Honasa Consumer | 477.05 | 61.6 | 15,553 | 0.63 | 90.5 | 118.4 | 756.0 | 27.0 | 19.2 |
| Median | 454.55 | 38.2 | 15,971 | 0.34 | 90.5 | 15.0 | 756.0 | 15.4 | 30.2 |
Competes with: Colgate-Palmolive India, Cupid Limited, Dabur India, Emami Limited, Gillette India Limited, Godrej Consumer Products, Procter & Gamble Hygiene and Health Care Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 464 | 496 | 488 | 471 | 554 | 462 | 518 | 534 | 595 | 538 | 602 | 657 | 756 |
| Expenses | 435 | 456 | 454 | 438 | 508 | 493 | 491 | 507 | 549 | 490 | 536 | 580 | 646 |
| Material Cost | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Change in Inventories | 21 | 0.79 | 0.78 | 26 | -27 | -11 | |||||||
| Purchases of Stock-in-Trade | 135 | 171 | 158 | 164 | 222 | 240 | |||||||
| Employee Cost | 48 | 60 | 60 | 71 | 71 | 66 | |||||||
| Other Expenses | 303 | 318 | 272 | 276 | 314 | 350 | |||||||
| Operating Profit | 29 | 40 | 34 | 33 | 46 | -31 | 26 | 27 | 46 | 48 | 65 | 77 | 110 |
| OPM % | 6.31 | 8.11 | 7.06 | 7.03 | 8.32 | -6.65 | 5.05 | 5.06 | 7.69 | 8.86 | 11 | 12 | 15 |
| Other Income | 13 | 7 | 11 | 19 | 19 | 20 | 19 | 21 | 24 | 20 | 16 | 19 | 23 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | -4.80 | 0 | 0 | |||||||
| Interest | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 6 | 8 | 10 | 9 | 11 | 13 | 12 | 11 | 12 | 11 | 11 | 10 |
| Profit before tax | 34 | 39 | 35 | 39 | 52 | -24 | 29 | 32 | 56 | 53 | 67 | 82 | 119 |
| Tax % | 27 | 25 | 25 | 22 | 23 | -24 | 12 | 22 | 26 | 26 | 25 | 15 | 24 |
| Net Profit | 25 | 29 | 26 | 30 | 40 | -19 | 26 | 25 | 41 | 39 | 50 | 69 | 90 |
| EPS in Rs | 1.90 | 2.16 | 0.80 | 0.94 | 1.24 | -0.57 | 0.80 | 0.77 | 1.27 | 1.21 | 1.54 | 2.13 | 2.77 |
| Diluted EPS in Rs | 0.77 | 1.26 | 1.20 | 1.54 | 2.12 | 2.76 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 460 | 943 | 1,493 | 1,920 | 2,067 | 2,392 | 2,553 |
| Expenses | 1,794 | 932 | 1,470 | 1,782 | 1,997 | 2,156 | 2,252 |
| Material Cost | 0 | 0 | |||||
| Change in Inventories | -43 | -0.23 | |||||
| Purchases of Stock-in-Trade | 656 | 715 | |||||
| Employee Cost | 200 | 263 | |||||
| Other Expenses | 1,185 | 1,179 | |||||
| Operating Profit | -1,334 | 12 | 23 | 138 | 70 | 236 | 300 |
| OPM % | -290 | 1.20 | 1.50 | 7 | 3.40 | 10 | 12 |
| Other Income | 12 | 21 | -132 | 49 | 77 | 79 | 77 |
| Exceptional items (within Other Income) | 0 | -4.80 | |||||
| Interest | 1 | 3 | 7 | 9 | 13 | 13 | 13 |
| Depreciation | 2 | 7 | 25 | 31 | 45 | 44 | 44 |
| Profit before tax | -1,325 | 22 | -141 | 147 | 90 | 257 | 321 |
| Tax % | 1 | 36 | 7 | 25 | 19 | 22 | |
| Net Profit | -1,332 | 14 | -151 | 111 | 73 | 200 | 249 |
| EPS in Rs | -13,06,098 | 15,262 | -10 | 3.45 | 2.24 | 6.15 | 7.65 |
| Diluted EPS in Rs | 2.23 | 6.12 | |||||
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 49 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 39%
- 3 years
- 17%
- TTM
- 21%
Compounded profit growth
- 10 years
- —
- 5 years
- 17%
- 3 years
- 118%
- TTM
- 242%
Stock price CAGR
- 10 years
- —
- 5 years
- —
- 3 years
- —
- 1 year
- 68%
Return on equity
- 10 years
- —
- 5 years
- —
- 3 years
- —
- Last year
- 16%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 136 | 324 | 325 | 325 |
| Reserves | -1,765 | -1,087 | -1,323 | 771 | 855 | 1,086 |
| Borrowings | 1,954 | 1,853 | 1,885 | 131 | 136 | 135 |
| Other Liabilities | 114 | 271 | 288 | 413 | 492 | 560 |
| Total Liabilities | 303 | 1,036 | 986 | 1,640 | 1,808 | 2,107 |
| Fixed Assets | 21 | 342 | 252 | 299 | 302 | 489 |
| CWIP | 0 | 2 | 0 | 0 | 0 | 0 |
| Investments | 164 | 339 | 260 | 292 | 305 | 272 |
| Other Assets | 117 | 354 | 474 | 1,049 | 1,201 | 1,346 |
| Total Assets | 303 | 1,036 | 986 | 1,632 | 1,790 | 2,092 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 30 | 45 | -52 | 235 | 102 | 141 |
| Cash from Investing Activity | -21 | -505 | 40 | -470 | -145 | -17 |
| Cash from Financing Activity | -1 | 481 | -14 | 337 | -31 | -38 |
| Net Cash Flow | 8 | 21 | -26 | 102 | -74 | 86 |
| Free Cash Flow | 29 | 42 | -63 | 224 | 82 | 134 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 27 | 28 | 32 | 30 | 23 | 30 |
| Inventory Days | 114 | 86 | 99 | 83 | 105 | 92 |
| Days Payable | 221 | 219 | 161 | 185 | 212 | 193 |
| Cash Conversion Cycle | -80 | -105 | -30 | -71 | -84 | -71 |
| Working Capital Days | -2 | -12 | 8 | -10 | -17 | -9 |
| ROCE % | 5 | 3 | 16 | 8 | 19 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-331inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
volume growth %
30.50pct
2026-06-30
News
News and filings about Honasa Consumer Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Plastic packaging material (crude-linked)
- Surfactants (SLES/SLS, palm/petchem-derived)
Depends on the price of
- Crude Oil Brent
Sells to
- Amazon India · BPC finished goods via online marketplace
- FSN E-Commerce Ventures Limited · Beauty & personal care finished goods (Mamaearth, The Derma Co.) sold via Nykaa marketplac…
- Flipkart · BPC finished goods via online marketplace
Buys from
- Unicommerce Esolutions Limited · eCommerce enablement SaaS — Uniware OMS/WMS (published case study, 99.99% fulfilment)
- Zaggle Prepaid Ocean Services Limited · spend management SaaS, prepaid/commercial cards and rewards solutions
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Personal Care
- Classification
- Fast Moving Consumer Goods › Personal Care
- ISIN
- INE0J5401028
News impact
Big market events that reach Honasa Consumer Limited, and how the effect spreads.
29 Sept, 10:17 IST · Market event · high impact
Honasa Consumer Share Price Falls Over 3% On Block Deal Buzz
Early investors plan to sell up to 89 lakh Honasa shares in a block deal, so Honasa shares fell over 3%, hurting current holders while block buyers may get a discount and rivals see no change.
Who it hits first
- Honasa Consumer, which sells Mamaearth beauty and baby-care products, fell over 3% after news that early backers may sell up to 89 lakh shares in one block trade.
- Peak XV Partners, Sequoia Capital Global Growth Fund III and Redwood Trust are the likely sellers, cashing out part of their early stake.
- A big sale like this adds many shares for sale at once, so the price dips until new buyers absorb the block.
Who may gain
- Block-deal buyers, who may pick up Honasa shares at a discount to the market price
- Short-term traders who sold early on the buzz and can buy back lower after the sale
- Patient buyers who want Honasa for its brands and get a cheaper entry on the dip
Along the supply chain
Downstream
No downstream change — Nykaa, the beauty retailer that sells Honasa products, sees the same shopper demand; only Honasa's share price moves.
Upstream
No upstream change — software and order-service providers to Honasa see no order change when investors sell shares.
Where demand moves
Business
No change in shop demand — people buy the same Mamaearth creams and shampoos; only share ownership changes hands.
Capital
Selling pressure on Honasa shares — up to 89 lakh shares offered in the block must find new buyers, so the price slips until the block clears.
How it spreads across sectors
Fast Moving Consumer Goods
No real ripple — a single-company share sale does not change soap, cream or shampoo sales for Dabur, Godrej Consumer, Emami or Colgate.
When it plays out
Immediate
In 1-7 days, Honasa stays weak as the 89-lakh-share block hangs over the price and clears.
Medium term
In 1-6 months, price follows business — Mamaearth growth and profits matter, not the old investor exit.
Short term
In 1-4 weeks, shares steady once the block finds buyers and focus returns to sales and margins.
19 Jun, 04:22 IST · Market event · medium impact
L'Oreal acquires majority stake in Innovist, parent of D2C beauty brand Bare Anatomy
Who it hits first
- HONASA: HONASA (Mamaearth): direct listed D2C beauty competitor faces sharper L'Oreal heat. PE 65.1 >> FMCG median 25.7 (premium); ROE 15.7 above 11.4; pledge 4.2%.
Who may gain
- HINDUNILVR: HUL premium beauty validation. PE 33.5 above FMCG median 25.7; ROE 31.0 well above 11.4. Lakme/Dove portfolio benefits from category premiumisation.
- DABUR: DABUR ayurvedic + beauty portfolio. PE 39.7 above FMCG median 25.7; ROE 17.2 above 11.4.
- EMAMILTD: EMAMI premium personal care exposure. PE 25.0 at FMCG median 25.7; ROE 30.2 well above 11.4.
Along the supply chain
Downstream
NYKAA distribution channel benefits from Innovist brand growth; e-commerce volume growth; influencer/MarTech (AFFLE) benefits from increased beauty ad spend.
Upstream
Specialty chemicals (FINEORG, AARTIIND) and fragrance ingredient makers benefit from L'Oreal scaling Innovist with global supply chain.
Where demand moves
Business
L'Oreal majority in Innovist (Bare Anatomy) intensifies premium D2C beauty competition. HONASA Mamaearth faces direct pressure. NYKAA dual-edged: category growth positive, brand-side competition negative. Listed FMCG (HUL, DABUR, EMAMI) gain category premium validation.
Capital
Capital flows into premium beauty validation names — NYKAA, HONASA mixed; HUL premium-beauty exposure (Lakme, Dove, Pond) gets re-rating support. D2C-focused specialty chemicals (FINEORG, CLEAN) may see investor interest.
How it spreads across sectors
Beauty & Personal Care
M&A premium for D2C beauty assets
D2C
Exit liquidity validated — early-stage VCs see clearer exit pathway
FMCG
D2C premium beauty acquisition validates HUL, DABUR Vatika premium bet
codex additions
Commodity angle
Cc skip reason
no_commodity_link
When it plays out
Immediate
HONASA -3-5% on competitive intensity; NYKAA mixed (+/-1-2%); HUL, DABUR +1-2% sympathy.
Medium term
India premium beauty TAM doubles 2026-2028; consolidation cycle continues with more global PE/strategic interest.
Short term
Q1FY27 D2C beauty commentary will reveal L'Oreal-Innovist's pricing strategy — sustained re-rating or fade.
Other sectors it reaches
- {"causal_chain":"Premium beauty consolidation raises demand for differentiated actives, surfactants, aroma chemicals, preservatives and formulation inputs as large strategics scale acquired D2C brands.","direction":"positive","example_tickers":["FINEORG","AARTIIND","CLEAN"],"magnitude":"medium","notes":"Benefit is indirect and depends on domestic sourcing versus imported formulations.","sector":"Specialty Chemicals \u0026 Fragrance Ingredients","time_horizon":"1_to_6_months"}
- {"causal_chain":"Beauty and personal-care premiumization increases need for tubes, pumps, labels, cartons, rigid plastics and sustainable packaging as brands upgrade shelf appeal and omnichannel formats.","direction":"positive","example_tickers":["UFLEX","HUHTAMAKI","EPL"],"magnitude":"medium","notes":"EPL has direct relevance through laminated tubes used in oral care, beauty and personal care.","sector":"Packaging","time_horizon":"1_to_6_months"}
- {"causal_chain":"Global FMCG buyers acquiring Indian D2C brands may outsource incremental production before investing in captive capacity, lifting demand for third-party formulation and manufacturing partners.","direction":"positive","example_tickers":["HINDUNILVR","GODREJCP","JYOTHYLAB"],"magnitude":"small","notes":"Few pure-play listed beauty contract manufacturers exist on NSE, so tickers are imperfect proxies through consumer manufacturing exposure.","sector":"Contract Manufacturing / CDMO for Consumer Products","time_horizon":"1_to_6_months"}
- {"causal_chain":"Strategic validation of D2C beauty increases paid discovery, marketplace launches, brand-store investments and online assortment expansion across premium personal care.","direction":"positive","example_tickers":["NYKAA","INDIAMART","MSTCLTD"],"magnitude":"medium","notes":"NYKAA is mixed: competitive pressure from L'Oreal-controlled brands, but category traffic and GMV validation are supportive.","sector":"E-commerce Marketplaces \u0026 Online Retail Enablement","time_horizon":"immediate"}
- {"causal_chain":"Beauty D2C brands rely heavily on influencer marketing, performance ads, CRM and content commerce; acquisition-driven competition can raise customer-acquisition spending across the category.","direction":"positive","example_tickers":["AFFLE","NAZARA","TIPSFILMS"],"magnitude":"small","notes":"Listed proxies are broad digital media/ad-tech plays rather than beauty-specific vendors.","sector":"Digital Advertising \u0026 MarTech","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"Premium beauty brands compete through creator-led education, celebrity collaborations, reels, tutorials and launch campaigns, increasing spend on digital content and influencer ecosystems.","direction":"positive","example_tickers":["SAREGAMA","TIPSINDLTD","ZEEL"],"magnitude":"small","notes":"Impact is diffuse and more visible in campaign activity than near-term earnings.","sector":"Media, Influencer \u0026 Entertainment Platforms","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"Scaling D2C beauty requires faster fulfillment, returns handling, marketplace warehousing and cold/controlled storage for certain formulations, supporting third-party logistics demand.","direction":"positive","example_tickers":["DELHIVERY","TCI","BLUEDART"],"magnitude":"small","notes":"Beauty is a small share of total logistics volumes, but high SKU complexity makes the category operationally relevant.","sector":"Logistics \u0026 Warehousing","time_horizon":"1_to_6_months"}
- {"causal_chain":"D2C beauty brands that receive strategic backing often move from online-only to omnichannel kiosks, shop-in-shops and mall stores, lifting demand for premium retail space.","direction":"positive","example_tickers":["PHOENIXLTD","PRESTIGE","DLF"],"magnitude":"small","notes":"More relevant for premium malls and high-street retail than broad real estate.","sector":"Retail Real Estate / Malls","time_horizon":"1_to_6_months"}
- {"causal_chain":"Large FMCG-led acquisitions validate consumer-brand M\u0026A, potentially increasing deal financing, advisory mandates, founder liquidity and wealth-management flows.","direction":"positive","example_tickers":["ICICIBANK","KOTAKBANK","AXISBANK"],"magnitude":"small","notes":"Likely modest unless it triggers a broader consumer D2C transaction cycle.","sector":"Private Banks \u0026 Investment Banking / Wealth","time_horizon":"1_to_6_months"}
10 Apr, 10:14 IST · Market event · medium impact
Honasa Consumer Q4 Business Update — Goldman Sachs Raises Target
Who it hits first
- Honasa sees improved Q4, Goldman raises target
Who may gain
- None directly
Along the supply chain
Downstream
N/A
Upstream
N/A
Where demand moves
Business
Mamaearth gaining D2C market share
Capital
Goldman endorsement attracts institutional flows into new-age consumer names
How it spreads across sectors
FMCG
D2C brands gaining share signals disruption risk for incumbents
When it plays out
Immediate
Stock rallies on Goldman target hike
Medium term
Path to sustainable profitability determines re-rating
Short term
Actual Q4 results needed
9 Apr, 12:11 IST · Market event · medium impact
Honasa Consumer Posts Strong Q4 Business Update — Growth in Late Twenties
Who it hits first
- Honasa Consumer reports strong Q4 growth
Who may gain
- Honasa gains market share in D2C beauty
Along the supply chain
Downstream
None significant
Upstream
None significant
Where demand moves
Business
Consumer demand for natural beauty products growing
Capital
Growth stock momentum attracts retail flows
How it spreads across sectors
FMCG
Positive read for D2C brands
When it plays out
Immediate
Stock at 52-week high, 11% rally
Medium term
Profitability improvement needed to sustain valuation
Short term
Full Q4 results to confirm margins
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 28 Aug 2026 | unspecified | ₹3 |
|---|
Splits, bonuses & buybacks
- daily-prices repair: 7 rows from NSE's archive (replace 2, delete 0, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023
Bulk & block deals
| Date | Who | Bought / sold | Shares | Price |
|---|---|---|---|---|
| 29 Sep 2026 | PEAK XV PARTNERS INVESTMENTS VI | SELL | 1,07,55,495 | ₹450.22 |
| 29 Sep 2026 | FRANKLIN TEMPLETON MUTUAL FUND | BUY | 33,33,333 | ₹450.00 |
| 29 Sep 2026 | SEQUOIA CAPITAL GLOBAL GROWTH FUND III - U.S./ INDIA ANNEX FUND L.P. | SELL | 25,02,289 | ₹450.00 |
| 29 Sep 2026 | ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED | BUY | 17,77,777 | ₹450.00 |
| 25 Jun 2026 | SOFINA VENTURES S.A. | SELL | 41,78,384 | ₹424.07 |
| 22 May 2026 | MICROCURVES TRADING PRIVATE LIMITED | BUY | 30,00,845 | ₹392.12 |
| 22 May 2026 | MICROCURVES TRADING PRIVATE LIMITED | SELL | 30,00,845 | ₹392.35 |
| 22 May 2026 | NK SECURITIES RESEARCH PRIVATE LIMITED | BUY | 27,87,698 | ₹392.01 |
| 22 May 2026 | NK SECURITIES RESEARCH PRIVATE LIMITED | SELL | 27,87,698 | ₹392.18 |
| 22 May 2026 | QE SECURITIES LLP | BUY | 26,71,616 | ₹393.70 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-263 Sep 2026
- Earnings call19 Aug 2026
- Earnings call · Q1FY2713 Aug 2026
- Results presentation30 Jun 2026
- Earnings call · Q3FY2612 Feb 2026
- Annual report · 2024-251 Sep 2025
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.